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ABSTRACT 
Cardiovascular health is negatively affected by overactivity of the sympathetic nervous 
system (SNS) during rest. Heart rate variability (HRV) has been used to predict SNS activity. 
The study investigated effects of a placebo, caffeine, and preworkout supplement (double 
blinded) on short term HRV before and after an acute bout of resistance exercise. Twelve 
subjects completed a trial with each supplement. Caffeine and exercise showed a significant 
decrease for Low Frequency (LF) Power normalized units (n.u.) (p=0.005) and a significant 
increase for High Frequency (HF) Power n.u. (p=0.010) immediately post exercise compared to 
exercise with placebo. Known effects that the combination of caffeine and exercise have on SNS 
activity do not agree with results found for HF Power n.u. and LF Power n.u using traditional 
interpretation of these indices for SNS activity. This suggests that the relationship between the 
cardiovascular autonomic control system and HRV is more complex than previously thought. 
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1. INTRODUCTION 
Heart rate variability (HRV), in general terms, is the amount of beat-to-beat variation in 
the heart rate. HRV has been shown to act as an indicator for cardiovascular health [1], [7], [9]. 
Some ECG machines include software to perform HRV analysis. However, there is no control 
over which HRV indices are measured, limiting the opportunity for thorough analysis and 
satisfactory comparison between most HRV studies.  
HRV has recently been used as a non-invasive method for gaining insight into autonomic 
nervous system (ANS). While SNS activity is important for exercise because it increases heart 
rate, respiration rate, and blood flow to muscles, it is known that overactivity of the SNS during 
rest is often associated with multiple cardiovascular diseases (CVDs) such as hypertension and 
heart failure [6].  
SNS activity can also be elevated through ingesting caffeine [10]. Many Preworkout 
supplements contain caffeine and advertise performance boosts through increasing SNS activity, 
however it is unknown what effects these supplements have on SNS activity either during rest or 
after an exercise bout. Apart from caffeine, preworkout supplements may contain other 
ingredients that have unknown effects on SNS activity. Furthermore, these supplements are 
unregulated by the Food and Drug Administration (FDA), making it difficult to determine the 
ingredients and the effects of these ingredients. 
The purpose of this thesis was to determine the effect of a placebo, caffeine, and 
preworkout supplement on HRV, and, by inference, SNS activity. To accomplish this, an HRV 
software package was created to include the large number of standard HRV indices from [1]. 
Inclusion of the full set of standard indices increases the overlap of HRV indices among most 
other HRV studies for easier comparisons among studies. 
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2. BACKGROUND 
Changes in HRV are widely believed to stem from the influence of both SNS and 
parasympathetic nervous system (PNS) activity on the sinoatrial (SA) node [8]. Although HRV 
actually measures variability from the atrioventricular (AV) node, it has been shown to very 
accurately reflect variability in the SA node [8]. A historical overview of the evolution of HRV 
research is summarized in [9]. 
Typical HRV analysis consists of many numerical indices and is not characterized by a 
single index [1]. HRV analysis consists, most commonly, of two types of analysis: time and 
frequency domain analysis [1]. The purpose of these types of analysis is to describe beat-to-beat 
variability in numerous ways with the goal of gaining insight to the SNS and PNS activity [9].  
It is known that increased SNS activity increases heart rate while increased PNS activity 
decreases heart rate [9]. It has also been shown that heart rate changes occur synchronously with 
the respiration rate, otherwise known as respiratory sinus arrhythmia (RSA), providing 
information about SNS and PNS activity. Time domain analysis attempts to measure the 
variability of RSA as a measure of the relationship between SNS and PNS activity.  
It has also been shown that beat-to-beat variability does not occur as one single 
frequency, such as by the respiration rate, but has been shown to occur at numerous frequencies. 
This is the basis for the use of frequency domain analysis. Although very controversial, changes 
in heart rate that occur at frequencies greater than 0.04 Hz but less than 0.15 Hz have been 
shown reflect the combination of both SNS and PNS activity while changes in heart rate that 
occur at frequencies greater than 0.15 Hz but less than 0.40 Hz reflect PNS activity. Frequency 
domain analysis attempts to measure the contributions of various frequencies to overall beat-to-
beat variability. 
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To perform these analyses, the timing of a series of heart beats must be measured. This is 
typically achieved by measuring the electrical activity of the heart via an ECG waveform. There 
are two main lengths of time commonly used for HRV analysis: short term HRV analysis (5 
minutes) and long term HRV analysis (24 hours).  
Once a recording is completed, the R wave of each QRS complex is detected. Once each 
normal R wave is detected, the RR intervals (time between each RR interval in milliseconds) are 
determined. After visual confirmation that there are no abnormalities in the RR interval 
calculations, and the abnormal (or ectopic) R waves and subsequent RR intervals are rejected as 
part of analysis, the RR intervals are termed “NN” intervals (normal RR intervals),.  
The plot of the NN intervals vs time is commonly referred to as the “tachogram,” and 
will be referred to as the tachogram in this thesis. The time and frequency domain analysis 
methods are determined from the NN data in the tachogram. 
One idea brought forth by [3] noted the NN interval’s mathematical dependence on the 
heart rate (HR). They suggested a need for a correction procedure, which they developed [3]. 
The correction involves dividing each NN interval by the average NN interval. The end result is 
a unitless tachogram that no longer depends on its average value. 
2.1. Time Domain HRV Analysis 
Time domain analysis consists of determining statistical characteristics directly from the 
data on the tachogram. Some typical time domain indices that represent the time domain 
methods are shown in Table 1. All of those time indices are suggested for use by [1].  
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Table 1. Summary of Standard Time Domain Indices Used for HRV Analysis. 
Index Units Description Definition 
Mean NN ms The average of all NN intervals 1
𝑛
∑𝑁𝑁𝑖
𝑛
𝑖=1
 
Max NN ms The maximum of all NN intervals - 
Min NN ms The minimum of all NN intervals - 
SDNN ms The sample standard deviation of all NN 
intervals 
√
1
𝑛 − 1
∑(𝑁𝑁𝑖 − 𝜇)2
𝑛
𝑖=1
 
rMSSD ms The root mean square of successive 
differences 
√
1
𝑛 − 1
∑(𝑁𝑁𝑖+1 −𝑁𝑁𝑖)2
𝑛
𝑖=1
 
Ln(rMSSD) - The natural logarithm of the rMSSD ln(𝑟𝑀𝑆𝑆𝐷) 
pNNxx ms The percentage of ∆NN intervals that 
differ by more than xx ms 
− 
Triangular 
Index 
ms The total number of NN intervals divided 
by the max of the density distribution of 
NN intervals 
The total number of NN 
intervals divided by the max 
of the density distribution of 
NN intervals with a bin size 
of 
1
128
 𝑠 = 7.8125 𝑚𝑠 
Mean ∆NN ms The average of all ∆NN intervals 1
𝑛
∑∆𝑁𝑁𝑖
𝑛
𝑖=1
 
SDSD ms The sample standard deviation of 
successive differences (standard deviation 
of all ∆NN intervals) √
1
𝑛 − 1
∑(∆𝑁𝑁𝑖 − 𝜇)2
𝑛
𝑖=1
 
 
2.2. Frequency Domain HRV Analysis 
Frequency domain analysis consists primarily of determining the signal power of the 
tachogram over various frequency ranges [1]. Determining the signal power of a frequency range 
of the tachogram is achieved by integrating the power spectral density (PSD) of the tachogram 
over a desired frequency range. Commonly, the PSD is determined by two different methods: 
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non-parametric and parametric methods. Non-parametric methods consist of determining the 
PSD using a fast Fourier Transfer (FFT), and parametric methods consist of determining the PSD 
using an autoregressive (AR) model. Some typical frequency domain indices are shown in Table 
2. 
Table 2. Summary of Standard Frequency Domain Indices Used for HRV Analysis. 
Index Units Description Frequency Range 
(Hz) 
Total Power (TP) ms2 Variance of all NN intervals Approximately equal 
to 𝑓 ≤ ~0.4, but 
includes all 
frequencies. 
Very Low Frequency (VLF) 
Power 
ms2 Power in the VLF range 0 ≤ 𝑓 ≤ 0.04 
Low Frequency (LF) Power ms2 Power in the LF range 0.04 ≤ 𝑓 ≤ 0.15 
High Frequency (HF) Power ms2 Power in the HF range 0.15 ≤ 𝑓 ≤ 0.40 
LF:HF Ratio ms2 Ratio between LF and HF 
Power 
 
Low Frequency (LF) Power n.u. Normalized Power in the LF 
range. Equal to LF divided by 
the TP minus the VLF. 
 
High Frequency (HF) Power n.u. Normalized Power in the HF 
range. Equal to HF divided by 
the TP minus the VLF. 
 
 
2.2.1. Non-Parametric Method: Fast Fourier Transform (FFT) 
The FFT method calculates the discrete Fourier transform (DFT) of a discrete signal 
sampled at equal intervals using an FFT algorithm. The PSD, as determined by the FFT method, 
displays magnitudes at frequencies over the frequency range of zero Hz to one-half of the 
sampling frequency (Nyquist’s theorem) with a frequency spacing of ∆𝑓 =
1
𝑇
=
1
𝑁
𝑓𝑠
⁄
=
𝑓𝑠
𝑁
 where 
𝑇 is the length of the signal in seconds, 𝑁 is the number of data points, and 𝑓𝑠 is the sampling 
frequency. Sometimes, the PSD may have a small frequency resolution (large ∆𝑓) which makes 
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it difficult to see the contribution of various frequencies to the PSD. It is possible to increase the 
frequency resolution (decrease ∆𝑓), if desired, by performing “zero padding.” Zero padding 
consists of adding zeros to the end of the signal. Zero padding increases 𝑁, therefore increases 
frequency resolution (decreases ∆𝑓). Once the PSD has been determined, the PSD is integrated, 
such as by the trapezoidal method (the integration method is arbitrary), over a desired frequency 
range to determine the signal power over a chosen frequency range. Zero padding can also be 
used to create a ∆𝑓 that makes integration more convenient, such as making sure that the ∆𝑓 
allows for there to be data points at specific frequencies of concern (the end points for the 
frequency ranges for HRV analysis).  
2.2.2. Parametric Method: Autoregressive (AR) Modeling 
Determining the PSD by AR modeling consists of creating an AR model which is used as 
a prediction model to model a signal based on a linear combination of previous data points, each 
with a specific weight. The chosen number of previous data points used in the model is the AR 
model order. The PSD, as determined by the AR model, displays the magnitudes at frequencies 
over the frequency range of zero Hz to one-half of the re-sampling frequency (Nyquist’s 
theorem). Unlike the PSD by FFT, the PSD by the AR method is a continuous function and can 
be plotted with any frequency spacing ∆𝑓 with no modification to the data of the interpolated 
tachogram such as zero padding. This allows for easier integration, such as by the trapezoidal 
method, of the waveform as well to determine the signal power over a chosen frequency range, 
since integrating the continuous PSD may be very difficult. 
2.2.3. Interpolated Tachogram (Cubic Spline) 
An issue with determining the PSD by either FFT or AR modeling is that both methods 
require that the set of data points be spaced at equal intervals, which is not the case of the 
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tachogram. To represent the tachogram with data points at equal intervals, some method of 
interpolation must be performed. A common method of interpolation is to create a cubic spline 
and re-sample the cubic spline at some chosen re-sampling frequency. Note that the sampling 
frequency of the ECG is typically not equal to the re-sampling frequency of the cubic spline. 
2.2.3.1. Cubic Spline Re-Sampling Frequency 
It is important to choose an appropriate re-sampling frequency to satisfy the needs of the 
frequency domain analysis. One constraint in the choosing of the re-sampling frequency is 
determined by applying Nyquist’s theorem. According the Nyquist’s theorem, the re-sampling 
frequency must be more than twice as large as the highest frequency of concern. The highest 
frequency of concern is 0.4 Hz (the upper bound on the high frequency range for HRV analysis). 
Therefore the first constraint is that the re-sampling frequency 𝑓𝑠 > 2 ∗ (0.4 𝐻𝑧) = 0.8 𝐻𝑧.  
The second constraint comes from properties of the PSD by both the FFT and AR model 
methods. For the FFT method, the frequency spacing is directly proportional to the re-sampling 
frequency, therefore the smaller the re-sampling frequency the smaller the frequency spacing. A 
small frequency spacing is always preferred over a large frequency spacing because it gives a 
more accurate representation of the PSD, and it also allows for more accurate integration when 
estimating the power of a chosen frequency range.  
For the AR method, if the re-sampling frequency is large, the model order of the AR 
model must also be large to examine frequency ranges of concern for HRV, resulting in a more 
complex and undesirable model. The shape of the PSD, as far as the number of peaks is the same 
no matter the re-sampling frequency. But what does change is the actual frequencies at which 
these peaks occur. With a low re-sampling frequency, the first peak on the PSD may occur at 0.1 
Hz and the last peak may occur at 0.3 Hz (both within ranges of concern for HRV), but with a 
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high re-sampling frequency, the first peak on the PSD may occur at 10 Hz and the last peak may 
occur at 30 Hz (not within ranges of concern for HRV). The conclusion is that, to avoid having a 
large AR model order, it is desirable to have a small re-sampling frequency. Some common re-
sampling frequencies are 2-5 Hz [8]. All of those re-frequencies satisfy the constraints discussed 
above. 
2.2.3.2. Interpolated Tachogram with Zero Mean 
Before the PSD of the interpolated tachogram is determined by the FFT or AR modeling 
method, the mean of the interpolated tachogram is typically subtracted from each data point on 
the interpolated tachogram, creating an interpolated tachogram with zero mean. If the mean from 
the interpolated tachogram is not removed, there will be a very large signal power at 0 Hz. If the 
total power of the interpolated tachogram were to be determined (by integrating the entire 
frequency range from 0 Hz to the one-half of the re-sampling frequency), the integration would 
involve the very large value at 0 Hz. There is no interest in determining the signal power 
contribution at 0 Hz, just the signal power associated with nonzero frequencies, hence the term 
heart rate variability.  
2.3. Correction for Mean Heart Rate (HR) 
The non-linear relationship between NN intervals and heart rate (HR) was pointed out by 
[3], but ignored by many if not most HRV researchers. Equation 1 describes the relationship 
between an NN interval and heart rate. This relationship is also shown in Figure 1. 
 𝑁𝑁 𝐼𝑛𝑡𝑒𝑣𝑎𝑙 (𝑚𝑠) =
60 𝑏𝑝𝑚
𝐻𝑅 (𝑏𝑝𝑚)
∗ 1000 𝑚𝑠. (1) 
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Figure 1. Relationship Between the NN Interval and Heart Rate. The figure shows how an NN 
interval is inversely proportional to the HR. At low HRs, the NN intervals are long; at high HRs, 
the NN intervals are short. The figure is a re-creation of a figure found in [3]. 
 
At low HRs, a small fluctuation in HR creates a large change in NN interval. At high 
HRs, the same small absolute fluctuation in HR creates a much smaller absolute change in NN 
interval. This suggests that the variability in NN intervals is dependent on the HR [3]. Figure 2 
shows how the variability in HR creates a different variability in NN intervals, dependent on the 
HR. 
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Figure 2. Relationship Between Variability in NN Intervals and Variability in Heart Rate at 
Specific HRs. The top line represents a HR of 60 bpm and each line below it represents a 5 bpm 
increase in HR up to 100 bpm. This demonstrates that the variability in HR maps to a variability 
in NN intervals, but the mapping depends on the current HR (i.e. for a current HR of 60 bpm, a 
variability in HR of 30 bpm maps to a variability in NN intervals of ~520 ms, but for a current 
HR of 100 bpm, a variability in HR of 30 bpm maps to a variability in NN intervals of ~190 ms). 
The figure is a re-creation of a figure found in [3]. 
Dividing all NN intervals by the average NN and the corresponding HRs by the average 
HR, creates a linear relationship between the variability in HR and the variability in NN [3]. 
Because of the division, the remaining values are unitless. The relationship is shown in Figure 3. 
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Figure 3. Relationship Between Variability in NN Intervals and Variability in HR after 
Correction for Mean HR. This demonstrates that after a correction for mean HR, a variability in 
HR maps to variability in NN intervals, but the variability in NN intervals is no longer dependent 
on the current HR. The figure is a re-creation of a figure found in [3]. 
 
Dividing the tachogram by the average NN interval creates a linear relationship between 
the variability in HR and the variability in NN interval for all HRs [3]. Because of the 
mathematical properties of the correction, the result of this correction amplifies HRV for 
tachograms with an average NN interval less than 1000 ms (HR of 60 bpm), and suppresses 
HRV for tachograms with an average NN interval greater than 1000 ms. 
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3. METHODS 
The goal of this thesis was to determine the how a placebo, caffeine, and preworkout 
supplement affected SNS activity as determined by HRV analysis. The effects were tested during 
rest prior exercise and after the conclusion of an exercise bout. The study was completed with 
IRB approval from NDSU (Protocol #HE15244). 
The group of subjects used in this study all fit a specific criteria as discussed below. Each 
subject came in 4 separate sessions (a familiarity session and 3 trial sessions), each separated by 
a minimum of 48 hours. 
The familiarity session consisted of each subject completing a questionnaire to confirm 
that they qualify for the study, filling out an informed consent form, and performing an isometric 
muscle contraction for both elbow flexion and extension on a Biodex to determine the peak 
maximal force isometric muscle force for both elbow flexion and extension. This peak maximal 
force was then used to determine the load for the exercise protocol described below. 
Each trial session involved the consumption of either a placebo, caffeine, or preworkout 
supplement followed by an exercise protocol. Each subject completed a trial with each of the 
three supplements. The study was double blinded (neither the researcher nor the subject knew the 
content of the supplement consumed, which was randomly coded for later decoding and data 
interpretation) so that there was no psychological influence on the subject during each trial. It 
was during the trial sessions that ECG recording were completed for HRV analysis at the 
specific times discussed below. Each trial started at a scheduled time between 6:00 and 9:30 AM 
and the subjects were told to not eat the morning prior to each trial. 
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3.1. Preworkout Procedure 
One of the important aspects of the experiment was the selection criteria for the subjects. 
Also, it was necessary to determine what would be used as well as the doses for the placebo, 
caffeine, and preworkout supplements. Once the experiment was completed, which also included 
numerous ECG recordings, methods of HRV analysis had to be determined. 
3.1.1. Subject Selection 
The 12 subjects selected for this study were all males aged 18 to 35 years. Each subject 
also must have reported that they participated in upper and lower body resistance exercise 2-3 
days per week for the past 6 months. It was also required that each subject reported that they 
were a habitual caffeine user, which was defined as consuming 100-500 mg of caffeine daily. A 
subject was excluded if they: 
 Were a current smoker. 
 Were currently taking any prescription medications that interact with caffeine. 
 Were currently taking anabolic steroids. 
 Have had any current or previous cardiovascular, musculoskeletal, or neurological 
medical problems. 
 Were known to have had allergic reactions to drugs, chemicals, or food 
ingredients including milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, and 
soybeans. 
 Had consumed other dietary supplements (other than vitamins) within the past 30 
days. 
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3.1.2. Supplement 
The study consisted of three supplements: a placebo, caffeine, and preworkout. The 
placebo supplement consisted of a corn starch mix with a fruit punch flavored, 5 calorie 
sweetened drink (Crystal Light, Northfield, IL). The caffeine supplement consisted of a 
commercially available caffeine pill, ground, using a mortar and pestle in 350 mg doses. It was 
then mixed with the same fruit punch flavored drink as the fruit punch flavored drink as was the 
placebo supplement. The preworkout supplement used in this study was the Arnold “pre-
workout” powder (MusclePharm). A 1 scoop (6 gram) dose of the supplement was used for the 
preworkout supplement in this study. The label on the back of this particular preworkout 
supplement is shown in Figure 4. 
 
Figure 4. Label for Arnold “Pre-Workout” Supplement (MusclePharm), Which was Used as the 
Preworkout Supplement for this Study. The label includes details about the ingredients that are 
claimed to be in the supplement. 
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3.1.3. Procedure 
Before the experiment started, each subject was prepped with the placement of 10 ECG 
electrodes to allow for a 12 lead ECG recording. Once prepped, each subject was told to sit 
upright in a chair and relax. ECG “monitoring” was started, and the experiment was postponed 
until the subject’s heart rate seemed to reach a baseline. Once this occurred, the procedure shown 
in Figure 5 was followed. Each ECG recording measurement was 5 minutes long, which is the 
typical length of time for a short-term HRV analysis [1]. 
 
Figure 5. Experimental Procedure. The numbers at the top of the figure represent the 5 minute 
ECG measurements that were taken. Measurement #1 is taken prior to supplement consumption. 
Measurement #2 is taken 30 minutes post supplement consumption. Measurement #3 is taken 
immediately post exercise. Measurement # 4 is taken 60 minutes post supplement consumption. 
Each block on the timeline refers to the length of time that passed during each portion of the 
procedure. 
3.1.3.1. Exercise Protocol 
The exercise protocol consisted of 5 sets of 10 reps of elbow flexion and extension on the 
Biodex. There was a one minute recovery period between each of the 5 sets. The force load was 
set at 50% of the peak maximal isometric force for both elbow flexion and extension that was 
determined during the familiarity session. 
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3.2. Heart Rate Variability (HRV) Measures 
The ECG recordings were performed using an PC-ECG 1200S (Norav) with a sampling 
frequency of 500 Hz. There were three built-in filters that were used during the recording (low 
pass filter for high frequency noise, 60 Hz notch filter, and a filter for ridding the signal of noise 
from muscle contractions). The data files were extracted from the machine for HRV analysis. 
HRV analysis consisted of creating a tachogram and performing time and frequency domain 
analysis on the tachogram. Because performing these tasks consists of many complex 
components, an interactive software package was created in MATLAB to calculate all measures 
easily and efficiently. Because the software package uses many built-in MATLAB functions, it 
was necessary to validate the performance of the built-in MATLAB functions. Validation was 
completed by simulating a tachogram and determining HRV from the tachogram using the 
MATLAB functions and comparing the results to HRV as determined by hand calculations. The 
validation is shown in Appendix D. 
3.2.1. Tachogram (NN Intervals vs Time) 
To perform time and frequency domain analysis on an ECG recording, the tachogram 
must be determined. There are a few steps that must be performed to determine the tachogram 
including R wave peak and RR interval detection as well as ectopic beat and RR interval 
rejection, and plotting of the normal RR intervals (NN intervals) vs time. If the MATLAB 
software package either did not detect an R wave or RR interval or detected an R wave or RR 
interval that was not in fact an R wave or RR interval, the software package offered a graphical 
user interface (GUI) feature so that these things could be interactively modified. A screenshot of 
the GUI is shown in Figure 6. 
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Figure 6. Graphical User Interface (GUI) Within MATLAB-Created HRV Software Package. 
The GUI consists of a plot showing the ECG, detected R wave peaks with numbers, detected NN 
intervals with numbers, and controls for interactively editing the data. The GUI offers controls 
for adding R wave peaks and NN intervals as well as offers controls for deleting previously 
detected R wave peaks and NN intervals. 
3.2.1.1. R Wave Peak Detection and Rejection of Ectopic/Missing Heart Beats 
The RR intervals were determined by calculating the amount of time between R wave 
peaks. After visual inspection and editing of the R wave peaks and RR intervals, the remaining 
normal RR intervals (NN intervals) were kept. The ECG, detected R wave peaks, and NN 
intervals were plotted. If any errors were detected, they were interactively changed. Once 
everything seemed correct, the tachogram could be used for HRV analysis. 
An example of a tachogram from a 5 minute ECG recording taken during this study is 
shown in Figure 7. 
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Figure 7. Sample Tachogram (NN intervals vs Time). The sample tachogram was from a 5 
minute ECG recording completed during the study. 
3.2.2. Time Domain Analysis 
The time domain indices in Table 1 were determined directly or indirectly from the 
tachogram. The time domain indices determined indirectly from the tachogram include those that 
use information about the ∆NN intervals. Therefore, the ∆NN intervals of the tachogram were 
plotted vs time. An example of the ∆NN intervals vs time from a 5 minute ECG recording taken 
during this study is shown in Figure 8. 
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Figure 8. Sample ∆NN Intervals vs Time. The sample ∆NN intervals vs time was from a 5 
minute ECG recording completed during the study. 
 
3.2.3. Frequency Domain Analysis 
Frequency domain analysis was calculated by first creating a cubic spline of the 
tachogram, re-sampling it, determining the PSD by FFT and AR modeling. The frequency 
domain indices from Table 2 were then determined from the two PSD plots. 
3.2.3.1. Interpolated Tachogram (Cubic Spline) 
A cubic spline was determined using the “not-a-knot” conditions. Appendix A discusses 
the details on how to calculate a cubic spline using such conditions. Once the cubic spline was 
determined, the interpolated tachogram was created by re-sampling the cubic spline at a 
frequency of 2 Hz (frequency is consistent with [2]). Finally, the mean of the interpolated 
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tachogram was subtracted from the interpolated tachogram to rid the signal power contribution 
from the 0 Hz frequency. 
3.2.3.2. Non-Parametric Method: Fast Fourier Transform (FFT) 
Once the cubic spline was re-sampled for each tachogram, a fast Fourier transform (FFT) 
was performed on the interpolated tachogram and modified to determine the power spectral 
density (PSD). Appendix B discusses the details on how to calculate a DFT and how to modify 
the DFT to determine the PSD. Each interpolated tachogram was zero padded to increase the 
frequency resolution (decrease ∆f) to force ∆f to be a common denominator of every endpoint of 
each frequency range of interest in frequency domain analysis (0, 0.04, 0.15, and 0.40 Hz), 
which results in no overlap or space between the bounds of integration for each respective 
frequency range of interest. A frequency spacing of ∆𝑓 = 1 ∗ 10−5 𝐻𝑧 was used, so the 
interpolated tachogram was zero padded to 𝑁 =
𝑓𝑠
∆𝑓
=
(2 𝐻𝑧)
(1∗10−5 𝐻𝑧)
= 200,000 𝑝𝑜𝑖𝑛𝑡𝑠. The PSD 
was then integrated using trapezoidal integration. The PSD is shown in Figure 9. 
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Figure 9. Sample Power Spectral Density (PSD) Using the Fast Fourier Transform (FFT) 
Method. The sample PSD was determined from a 5 minute ECG recording completed during this 
study. 
3.2.3.3. Parametric Method: Autoregressive (AR) Modeling 
Once the cubic spline was re-sampled for each tachogram, an autoregressive (AR) model 
was created for the interpolated tachogram and modified to determine the power spectral density 
(PSD). The AR model coefficients were determined by the Levinson-Durbin recursion 
algorithm.  Appendix B discusses the details on how to create an AR model using the Levinson-
Durbin recursion algorithm, and how to modify the AR model to determine the PSD.  A 16th 
order AR model is sufficient for an interpolated tachogram, with a re-sampling frequency of 2 
Hz, for a five minute ECG recording. The model order and re-sampling frequency were 
determined by investigation of previous HRV research [2]. The PSD amplitude was determined 
at points with a frequency spacing equal to ∆𝑓 = 1 ∗ 10−5 𝐻𝑧, consistent with the spacing 
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created by the FFT method, and then integrated using trapezoidal integration. The PSD is shown 
in Figure 10. 
 
Figure 10. Sample Power Spectral Density (PSD) Using the Autoregressive (AR) Modeling 
Method. The sample PSD was determined from a 5 minute ECG recording completed during this 
study. 
3.2.4. Correction for Mean Heart Rate (HR) 
Because there is a non-linear relationship between NN intervals and the average heart 
rate, traditional HRV analysis of the interpolated tachogram was performed alongside HRV 
analysis of the interpolated tachogram that was corrected for average HR. The interpolated 
tachogram that was corrected for average HR is shown in Figure 11. 
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Figure 11. Sample Tachogram (NN Intervals vs Time) after Correction for Mean Heart Rate. The 
figure shows a tachogram after dividing all of the values in the tachogram by the mean NN 
interval. 
3.3. Statistics 
A 3x4 (supplement by time) analysis of variance (ANOVA) with repeated measures (time 
and supplement). The significance level was set at p<0.05. If there was a violation of Mauchly’s 
Test of Sphericity, the Greenhouse-Geisser test was used to adjust p values as a result of the 
violation [13], [14], [15], [16]. When a supplement*time interaction was found, individual 
ANOVAs with repeated measures were performed at each time point (baseline, 30 minutes post 
consumption, post exercise, 60 minutes post consumption) to determine at which time point the 
interaction occurred. If a main effect was found, Bonferroni corrections were used to avoid type I 
error.  
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4. RESULTS 
There were a few statistically significant supplement*time interaction effects found for 
the frequency domain indices determined from the original tachogram. Those were FFT LF n.u. 
(p=0.023), FFT HF n.u. (p=0.048), AR LF n.u. (p=0.022), and AR HF n.u. (p=0.037). There 
were also a few statistically significant supplement*time interaction effects found for the 
frequency domain indices determined from the original tachogram after correction for mean HR. 
Those were FFT LF n.u. (p=0.023), FFT HF n.u. (p=0.048), AR LF n.u. (p=0.022), and AR HF 
n.u. (p=0.037). The reason there were statistically significant supplement*time interaction effects 
for the same frequency domain indices in those determined by the original tachogram and those 
from the original tachogram after correction for mean HR is because the correction for mean HR 
does not affect these indices because they are ratios of the power present, not indicators of 
magnitudes of power. Because of this fact, only the statistically significant supplement*time 
interaction effects for the frequency domain indices as determined by the original tachogram was 
discussed to avoid redundancy. There were also numerous statistically significant time effects 
found for the frequency domain indices as determined from the original tachogram and 
frequency domain indices as determined from the original tachogram after correction for mean 
HR, however they were not investigated further. 
The statistically significant supplement*time interaction effects found for the frequency 
domain indices determined from the original tachogram occurred immediately post exercise for 
the FFT LF n.u., FFT HF n.u., AR LF n.u., and AR HF n.u.. The information showing the 
statistically significant supplement*time effects for the FFT LF n.u., FFT HF n.u., AR LF n.u., 
and AR HF n.u. indices can be seen in Figure 12, Figure 13, Figure 14, and Figure 15 
respectively. 
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Figure 12. Fast Fourier Transform (FFT) Low Frequency (LF) Normalized Units (n.u.) before 
Correction for Mean Heart Rate. The figure shows the means of the placebo trial (closed circles), 
caffeine trial (closed squares), and preworkout trial (closed diamonds) at the baseline (Base), 30 
minutes post supplement consumption (30), immediately post exercise (Post), and 60 minutes 
post supplement consumption (60). There was a statistically significant difference between the 
caffeine and placebo trials immediately post exercise (p=0.005), which is represented by the star. 
Although there was not a statistically significant difference between the preworkout and placebo 
trials, there was however a trend (p=0.099). 
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.  
Figure 13. Fast Fourier Transform (FFT) High Frequency (HF) Normalized Units (n.u.) before 
Correction for Mean Heart Rate. The figure shows the means of the placebo trial (closed circles), 
caffeine trial (closed squares), and preworkout trial (closed diamonds) at the baseline (Base), 30 
minutes post supplement consumption (30), immediately post exercise (Post), and 60 minutes 
post supplement consumption (60). There was a statistically significant difference between the 
caffeine and placebo trials immediately post exercise (p=0.010), which is represented by the star. 
Although there was not a statistically significant difference between the preworkout and placebo 
trials, there was however a trend (p=0.139). 
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Figure 14. Autoregressive (AR) Low Frequency (LF) Normalized Units (n.u.) before Correction 
for Mean Heart Rate. The figure shows the means of the placebo trial (closed circles), caffeine 
trial (closed squares), and preworkout trial (closed diamonds) at the baseline (Base), 30 minutes 
post supplement consumption (30), immediately post exercise (Post), and 60 minutes post 
supplement consumption (60). There was a statistically significant difference between the 
caffeine and placebo trials immediately post exercise (p=0.008), which is represented by the star. 
Although there was not a statistically significant difference between the preworkout and placebo 
trials, there was however a trend (p=0.092). 
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Figure 15. Autoregressive (AR) High Frequency (HF) Normalized Units (n.u.) before Correction 
for Mean Heart Rate. The figure shows the means of the placebo trial (closed circles), caffeine 
trial (closed squares), and preworkout trial (closed diamonds) at the baseline (Base), 30 minutes 
post supplement consumption (30), immediately post exercise (Post), and 60 minutes post 
supplement consumption (60). There was a statistically significant difference between the 
caffeine and placebo trials immediately post exercise (p=0.014), which is represented by the star. 
Although there was not a statistically significant difference between the preworkout and placebo 
trials, there was however a trend (p=0.121). 
4.1. Summary of Statistics for Beats, NN, and ∆NN 
A summary of the basic statistics for the # of beats, NN intervals, and ∆NN intervals used 
for HRV analysis of the 5 minute ECG recordings for the placebo, caffeine, and preworkout 
supplement trials is shown in Table 3, Table 4, and Table 5 respectively. 
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Table 3. Placebo Trial: Summary of the Basic Statistics for # of Beats, NN Intervals, and ∆NN 
Intervals Used for HRV Analysis. The table shows the values for the # of beats, # of NN 
intervals, and the # of ∆NN intervals used for short term HRV analysis during the placebo trial. 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
# of Beats # 346.8 40.0 338.7 41.3 363.2 50.6 361.3 44.6 
# of NN # 345.4 40.1 336.3 42.1 361.3 51.1 359.1 44.7 
# of ∆NN # 344.1 40.2 334.1 43.2 359.7 51.6 357.3 44.9 
 
Table 4. Caffeine Trial: Summary of the Basic Statistics for # of Beats, NN Intervals, and ∆NN 
Intervals Used for HRV Analysis. The table shows the values for the # of beats, # of NN 
intervals, and the # of ∆NN intervals used for short term HRV analysis during the caffeine trial. 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
# of Beats # 332.3 34.3 319.4 40.6 359.0 55.1 352.2 38.1 
# of NN # 330.2 33.8 317.2 40.7 357.5 55.4 350.9 38.2 
# of ∆NN # 328.5 33.6 315.3 40.7 356.2 55.4 349.8 38.2 
 
Table 5. Preworkout Trial: Summary of the Basic Statistics for # of Beats, NN Intervals, and 
∆NN Intervals Used for HRV Analysis. The table shows the values for the # of beats, # of NN 
intervals, and the # of ∆NN intervals used for short term HRV analysis during the preworkout 
trial. 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
# of Beats # 342.3 51.9 326.8 43.3 359.8 54.2 356.1 44.2 
# of NN # 341.3 51.9 325.3 43.6 358.2 54.2 354.4 44.4 
# of ∆NN # 340.3 51.9 324.0 43.8 356.6 54.1 353.0 44.5 
 
4.2. Time Domain Indices 
The time domain indices consisted of those determined from the original tachogram and 
those determined from the original tachogram after being corrected for mean HR. There were no 
statistically significant supplement*time interaction effects found for any of the time domain 
indices determined from the original tachogram or the time domain indices determined from the 
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original tachogram after correction for mean HR. There were numerous statistically significant 
time effects found for the time domain indices as determined from the original tachogram and 
time domain indices as determined from the original tachogram after correction for mean HR, 
however they were not investigated further. 
4.2.1. Time Domain Indices from Original Tachogram 
A summary of the time domain indices as determined from the original tachogram for the 
placebo, caffeine, and preworkout supplements are shown in Table 6, Table 7, and Table 8 
respectively. 
Table 6. Placebo Trial Time Domain Indices as Determined from the Original Tachogram. The 
table shows the mean and standard deviation for each time domain index at each the baseline 
(Base), 30 minutes post supplement consumption (30), immediately post exercise (Post), and 60 
minutes post supplement consumption (60). 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
Min NN ms 684.8 79.0 670.7 59.0 642.5 60.3 653.8 54.0 
Max NN ms 1177.5 112.4 1224.5 163.2 1090.8 141.5 1129.5 131.9 
Mean NN ms 874.5 98.2 892.8 105.3 837.8 108.7 840.2 102.7 
SDNN ms 89.5 27.9 94.9 27.0 84.8 26.7 81.1 18.6 
RMSSD ms 55.8 30.4 60.8 27.2 49.6 21.8 46.4 19.4 
ln(RMSSD) - 3.91 0.48 4.03 0.42 3.81 0.45 3.76 0.39 
pNN50 % 23.3 15.6 27.3 14.1 23.9 16.7 19.4 13.6 
pNN40 % 31.0 15.9 35.4 14.6 31.3 18.2 27.0 14.2 
pNN30 % 40.9 15.4 46.2 14.2 41.3 18.6 38.1 14.8 
pNN20 % 55.7 12.8 60.1 12.6 55.5 16.5 52.8 13.5 
pNN10 % 74.2 8.6 77.3 7.5 74.2 10.6 73.8 8.9 
Mean ∆NN ms -0.08 0.43 -0.14 0.65 -0.09 0.49 0.01 0.53 
SD ∆NN ms 55.8 30.4 60.8 27.2 49.6 21.8 46.4 19.4 
Triangular 
Index 
- 16.8 3.7 17.8 3.4 18.5 5.6 16.1 4.4 
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Table 7. Caffeine Trial Time Domain Indices as Determined from the Original Tachogram. The 
table shows the mean and standard deviation for each time domain index at each the baseline 
(Base), 30 minutes post supplement consumption (30), immediately post exercise (Post), and 60 
minutes post supplement consumption (60). 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
Min NN ms 692.7 69.1 663.7 88.8 652.5 101.3 657.7 62.0 
Max NN ms 1238.7 152.1 1272.8 159.1 1137.5 141.2 1133.7 177.8 
Mean NN ms 911.1 92.5 950.0 111.6 853.1 128.6 860.2 89.6 
SDNN ms 104.9 30.2 114.3 33.6 92.5 28.9 89.6 24.3 
RMSSD ms 66.5 37.7 76.9 33.8 62.0 30.4 55.7 30.3 
ln(RMSSD) - 4.07 0.53 4.26 0.43 4.03 0.47 3.90 0.50 
pNN50 % 29.0 17.0 38.9 14.6 31.5 17.8 25.3 16.1 
pNN40 % 36.9 17.0 47.7 14.4 39.2 19.0 33.7 17.8 
pNN30 % 47.4 15.9 58.9 12.7 49.5 18.6 44.2 18.1 
pNN20 % 61.6 12.7 71.4 10.4 63.2 16.6 58.8 16.0 
pNN10 % 77.8 8.2 84.0 6.1 78.7 10.8 76.9 9.8 
Mean ∆NN ms -0.09 0.71 -0.03 0.79 -0.07 0.65 -0.05 0.48 
SD ∆NN ms 66.5 37.7 76.9 33.8 62.0 30.4 55.7 30.3 
Triangular 
Index 
- 19.2 3.5 19.3 4.1 20.3 5.8 18.0 4.6 
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Table 8. Preworkout Trial Time Domain Indices as Determined from the Original Tachogram. 
The table shows the mean and standard deviation for each time domain index at each the baseline 
(Base), 30 minutes post supplement consumption (30), immediately post exercise (Post), and 60 
minutes post supplement consumption (60). 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
Min NN ms 676.0 92.3 692.5 91.2 645.5 80.3 652.5 76.2 
Max NN ms 1147.3 170.7 1211.2 144.0 1140.2 156.8 1109.5 160.2 
Mean NN ms 897.5 148.4 929.8 117.0 847.1 123.9 852.9 99.9 
SDNN ms 92.0 22.2 97.9 28.6 88.2 16.5 86.2 28.2 
RMSSD ms 57.1 29.9 72.1 34.5 59.6 26.8 54.8 32.0 
ln(RMSSD) - 3.91 0.57 4.18 0.44 3.98 0.50 3.87 0.53 
pNN50 % 26.5 17.2 35.6 16.1 28.9 19.4 23.2 16.9 
pNN40 % 33.8 18.3 43.8 15.0 37.3 20.0 31.1 17.6 
pNN30 % 45.2 19.9 55.6 12.3 47.7 20.1 42.5 17.7 
pNN20 % 57.4 19.8 67.8 8.8 59.8 17.6 56.4 16.2 
pNN10 % 74.9 15.3 83.3 5.6 76.8 11.5 74.6 11.5 
Mean ∆NN ms 0.14 0.40 0.26 0.37 0.24 0.44 -0.02 0.64 
SD ∆NN ms 57.1 29.9 72.1 34.5 59.6 26.8 54.8 32.0 
Triangular 
Index 
- 18.6 4.7 17.8 3.9 18.2 3.9 16.4 3.8 
 
4.2.2. Time Domain Indices from Original Tachogram after Correction for Mean HR 
A summary of the time domain indices as determined from the original tachogram after 
correction for mean HR for the placebo, caffeine, and preworkout supplements are shown in 
Table 9, Table 10, and Table 11 respectively. 
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Table 9. Placebo Trial Time Domain Indices as Determined from the Original Tachogram after 
Correction for Mean HR. The table shows the mean and standard deviation for each time domain 
index at each the baseline (Base), 30 minutes post supplement consumption (30), immediately 
post exercise (Post), and 60 minutes post supplement consumption (60). 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
Min NN 10-3 783.2 26.1 755.8 64.0 772.1 59.6 782.7 51.3 
Max NN 10-3 1357.0 166.4 1382.2 205.2 1304.5 82.3 1349.8 124.5 
Mean NN 10-3 1000.0 0.0 1000.0 0.0 1000.0 0.0 1000.0 0.0 
SDNN 10-3 103.5 37.4 106.7 30.0 100.2 24.1 96.0 14.3 
RMSSD 10-3 64.9 40.5 68.8 34.6 57.9 20.7 54.7 20.1 
ln(RMSSD) - 4.05 0.49 4.15 0.41 4.00 0.37 3.95 0.35 
pNN50 % 28.2 15.0 32.6 13.0 31.0 15.0 26.4 12.4 
pNN40 % 36.6 14.4 40.9 12.7 38.7 14.9 34.8 12.8 
pNN30 % 48.6 12.8 52.4 11.1 50.4 13.4 46.6 12.1 
pNN20 % 61.6 10.2 65.9 9.4 64.2 11.8 61.1 10.6 
pNN10 % 79.9 6.3 82.0 5.4 80.8 7.6 79.7 6.4 
Mean ∆NN 10-3 -0.07 0.43 -0.14 0.72 -0.11 0.55 0.02 0.60 
SD ∆NN 10-3 64.9 40.5 68.8 34.6 57.9 20.7 54.7 20.1 
Triangular 
Index 
- 18.6 3.7 19.4 4.3 21.7 6.5 17.4 3.3 
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Table 10. Caffeine Trial Time Domain Indices as Determined from the Original Tachogram after 
Correction for Mean HR. The table shows the mean and standard deviation for each time domain 
index at each the baseline (Base), 30 minutes post supplement consumption (30), immediately 
post exercise (Post), and 60 minutes post supplement consumption (60). 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
Min NN 10-3 762.5 58.9 703.9 95.4 765.3 43.3 766.2 35.8 
Max NN 10-3 1366.0 172.6 1345.2 142.1 1349.9 195.2 1323.4 210.4 
Mean NN 10-3 1000.0 0.0 1000.0 0.0 1000.0 0.0 1000.0 0.0 
SDNN 10-3 115.5 32.1 120.6 33.3 110.2 36.7 103.9 26.0 
RMSSD 10-3 73.4 44.0 81.8 38.6 72.3 31.4 64.7 34.8 
ln(RMSSD) - 4.16 0.52 4.31 0.44 4.20 0.43 4.06 0.48 
pNN50 % 33.1 15.9 42.5 13.4 38.1 15.3 31.6 15.4 
pNN40 % 40.9 15.6 51.7 13.2 46.9 15.0 40.2 15.7 
pNN30 % 52.4 13.7 62.5 12.1 57.5 14.1 52.0 15.6 
pNN20 % 65.5 11.3 73.8 9.9 70.2 11.0 66.0 12.3 
pNN10 % 81.6 5.9 86.8 5.6 84.1 7.1 82.5 7.9 
Mean ∆NN 10-3 -0.11 0.78 -0.04 0.83 -0.06 0.74 -0.04 0.53 
SD ∆NN 10-3 73.4 44.0 81.8 38.6 72.3 31.4 64.7 34.8 
Triangular 
Index 
- 19.5 4.3 21.1 5.1 21.7 5.6 19.8 3.9 
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Table 11. Preworkout Trial Time Domain Indices as Determined from the Original Tachogram 
after Correction for Mean HR. The table shows the mean and standard deviation for each time 
domain index at each the baseline (Base), 30 minutes post supplement consumption (30), 
immediately post exercise (Post), and 60 minutes post supplement consumption (60). 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
Min NN 10-3 756.9 35.7 745.4 46.7 765.3 41.7 766.1 45.4 
Max NN 10-3 1284.7 112.4 1310.3 138.6 1352.3 130.2 1305.4 154.3 
Mean NN 10-3 1000.0 0.0 1000.0 0.0 1000.0 0.0 1000.0 0.0 
SDNN 10-3 103.1 24.8 106.6 33.0 104.4 15.4 101.1 29.9 
RMSSD 10-3 62.9 32.1 78.1 37.5 69.4 28.3 63.9 35.9 
ln(RMSSD) - 4.03 0.50 4.26 0.44 4.16 0.43 4.03 0.51 
pNN50 % 30.9 14.8 39.9 14.8 36.2 16.6 29.6 15.8 
pNN40 % 39.3 16.0 48.7 14.0 44.3 15.9 38.0 16.1 
pNN30 % 50.8 17.2 59.5 10.7 55.1 15.5 50.0 15.6 
pNN20 % 64.2 16.4 71.0 7.9 68.2 11.7 63.5 14.1 
pNN10 % 80.7 10.8 86.3 4.7 83.7 6.1 79.7 10.0 
Mean ∆NN 10-3 0.12 0.40 0.27 0.38 0.30 0.51 -0.06 0.70 
SD ∆NN 10-3 62.9 32.1 78.1 37.5 69.4 28.3 63.9 35.9 
Triangular 
Index 
- 19.4 3.5 19.9 5.0 20.1 3.2 18.2 3.7 
 
4.3. Frequency Domain Indices 
The frequency domain indices consisted of those determined from the original tachogram 
and those determined from the original tachogram after being corrected for mean HR. The 
statistically significant supplement*time interaction effects determined from the original 
tachogram and those determined from the original tachogram after correction for mean HR were 
discussed previously. There were numerous statistically significant time effects found for the 
frequency domain indices as determined from the original tachogram and frequency domain 
indices as determined from the original tachogram after correction for mean HR, however they 
were not investigated further. 
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4.3.1. Frequency Domain Indices from Original Tachogram 
A summary of the frequency domain indices as determined from the original tachogram 
for the placebo, caffeine, and preworkout supplements are shown in Table 12, Table 13. And 
Table 14 respectively. 
Table 12. Placebo Trial Frequency Domain Indices as Determined from the Original Tachogram. 
The table shows the mean and standard deviation for each frequency domain index at each the 
baseline (Base), 30 minutes post supplement consumption (30), immediately post exercise (Post), 
and 60 minutes post supplement consumption (60). 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
TP ms2 9307 7194 9682 5535 7752 4724 6885 2941 
FFT VLF ms2 4799 3690 5403 3782 3996 3229 3580 1859 
FFT LF ms2 2680 1415 2527 1149 2566 1507 2343 948 
FFT HF ms2 1689 2698 1604 1794 1095 939 864 709 
FFT LF:HF - 3.94 3.07 2.70 1.54 4.04 4.50 4.88 4.74 
FFT LF n.u. - 0.69 0.18 0.65 0.17 0.70 0.11 0.74 0.12 
FFT HF n.u. - 0.28 0.17 0.32 0.16 0.27 0.11 0.23 0.11 
AR VLF ms2 4729 3686 5274 3761 3960 3263 3524 1787 
AR LF ms2 2791 1506 2666 1194 2638 1564 2396 1088 
AR HF ms2 1645 2604 1598 1797 1060 882 866 717 
AR LF:HF - 4.10 3.25 2.87 1.71 4.09 4.13 5.28 5.83 
AR LF n.u. - 0.70 0.17 0.66 0.17 0.71 0.11 0.74 0.13 
AR HF n.u. - 0.27 0.16 0.31 0.16 0.26 0.10 0.23 0.12 
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Table 13. Caffeine Trial Frequency Domain Indices as Determined from the Original 
Tachogram. The table shows the mean and standard deviation for each frequency domain index 
at each the baseline (Base), 30 minutes post supplement consumption (30), immediately post 
exercise (Post), and 60 minutes post supplement consumption (60). 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
TP ms2 12022 7433 13750 7720 9419 6785 8688 4839 
FFT VLF ms2 5978 4162 7477 5939 5144 4523 4469 2851 
FFT LF ms2 3603 2470 3441 1351 2175 1090 2483 1502 
FFT HF ms2 2304 3441 2650 2689 1951 2272 1601 2014 
FFT LF:HF - 3.03 1.98 2.23 1.36 3.06 4.72 3.90 3.97 
FFT LF n.u. - 0.68 0.15 0.62 0.15 0.57 0.18 0.67 0.18 
FFT HF n.u. - 0.30 0.15 0.35 0.15 0.39 0.17 0.30 0.17 
AR VLF ms2 5877 4102 7351 5756 5025 4389 4396 2777 
AR LF ms2 3739 2510 3603 1345 2323 1139 2551 1499 
AR HF ms2 2266 3322 2612 2661 1922 2286 1606 2038 
AR LF:HF - 3.21 2.23 2.42 1.49 3.17 4.42 4.13 4.34 
AR LF n.u. - 0.69 0.15 0.63 0.16 0.59 0.18 0.68 0.18 
AR HF n.u. - 0.29 0.14 0.34 0.15 0.37 0.17 0.29 0.17 
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Table  14. Preworkout Trial Frequency Domain Indices as Determined from the Original 
Tachogram. The table shows the mean and standard deviation for each frequency domain index 
at each the baseline (Base), 30 minutes post supplement consumption (30), immediately post 
exercise (Post), and 60 minutes post supplement consumption (60). 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
TP ms2 8863 4556 10546 7010 7967 2707 8132 5803 
FFT VLF ms2 3747 1768 4608 3155 4123 1668 3735 2325 
FFT LF ms2 3534 2048 3510 2211 2158 1341 2772 2221 
FFT HF ms2 1480 1655 2243 2220 1538 1315 1493 1954 
FFT LF:HF - 4.50 3.15 2.77 2.68 3.05 3.65 3.77 3.57 
FFT LF n.u. - 0.74 0.13 0.64 0.13 0.60 0.21 0.69 0.14 
FFT HF n.u. - 0.24 0.13 0.33 0.12 0.36 0.20 0.28 0.13 
AR VLF ms2 3707 1743 4552 3155 4076 1567 3660 2246 
AR LF ms2 3622 2094 3584 2222 2216 1285 2859 2286 
AR HF ms2 1433 1589 2225 2239 1522 1296 1480 1940 
AR LF:HF - 4.86 3.40 2.84 2.56 3.18 3.88 3.90 3.56 
AR LF n.u. - 0.75 0.14 0.65 0.13 0.61 0.20 0.70 0.14 
AR HF n.u. - 0.23 0.14 0.32 0.12 0.35 0.19 0.27 0.13 
 
4.3.2. Frequency Domain Indices from Original Tachogram after Correction for Mean HR 
A summary of the time domain indices as determined from the original tachogram after 
correction for mean HR for the placebo, caffeine, and preworkout supplements are shown in 
Table 15, Table 16, Table 17 respectively. 
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Table 15. Placebo Trial Frequency Domain Indices as Determined from the Original Tachogram 
after Correction for Mean HR. The table shows the mean and standard deviation for each 
frequency domain index at each the baseline (Base), 30 minutes post supplement consumption 
(30), immediately post exercise (Post), and 60 minutes post supplement consumption (60). 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
TP 10-6 13106 13825 12460 8451 10515 4781 9519 2819 
FFT VLF 10-6 6491 6161 6684 4240 5458 3765 4873 1901 
FFT LF 10-6 3781 2705 3373 1983 3461 1555 3313 1065 
FFT HF 10-6 2619 5165 2189 3071 1461 1093 1189 969 
FFT LF:HF - 3.94 3.07 2.70 1.54 4.04 4.50 4.88 4.74 
FFT LF n.u. - 0.69 0.18 0.65 0.17 0.70 0.11 0.74 0.12 
FFT HF n.u. - 0.28 0.17 0.32 0.16 0.27 0.11 0.23 0.11 
AR VLF 10-6 6398 6155 6537 4213 5404 3775 4807 1820 
AR LF 10-6 3941 2893 3528 2028 3561 1636 3370 1159 
AR HF 10-6 2547 4983 2186 3080 1416 1031 1197 1001 
AR LF:HF - 4.10 3.25 2.87 1.71 4.09 4.13 5.28 5.83 
AR LF n.u. - 0.70 0.17 0.66 0.17 0.71 0.11 0.74 0.13 
AR HF n.u. - 0.27 0.16 0.31 0.16 0.26 0.10 0.23 0.12 
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Table 16. Caffeine Trial Frequency Domain Indices as Determined from the Original Tachogram 
after Correction for Mean HR. The table shows the mean and standard deviation for each 
frequency domain index at each the baseline (Base), 30 minutes post supplement consumption 
(30), immediately post exercise (Post), and 60 minutes post supplement consumption (60). 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
TP 10-6 14692 9543 15429 8967 13543 10169 11756 6898 
FFT VLF 10-6 6995 3860 8167 5614 7545 7814 5986 3898 
FFT LF 10-6 4474 3343 3878 1493 3169 1696 3366 1802 
FFT HF 10-6 3043 5310 3157 3722 2600 2585 2215 2852 
FFT LF:HF - 3.03 1.98 2.23 1.36 3.06 4.72 3.90 3.97 
FFT LF n.u. - 0.68 0.15 0.62 0.15 0.57 0.18 0.67 0.18 
FFT HF n.u. - 0.30 0.15 0.35 0.15 0.39 0.17 0.30 0.17 
AR VLF 10-6 6882 3826 8046 5552 7335 7482 5913 3898 
AR LF 10-6 4644 3425 4048 1432 3417 1954 3433 1759 
AR HF 10-6 2981 5116 3106 3657 2561 2603 2221 2870 
AR LF:HF - 3.21 2.23 2.42 1.49 3.17 4.42 4.13 4.34 
AR LF n.u. - 0.69 0.15 0.63 0.16 0.59 0.18 0.68 0.18 
AR HF n.u. - 0.29 0.14 0.34 0.15 0.37 0.17 0.29 0.17 
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Table 17. Preworkout Trial Frequency Domain Indices as Determined from the Original 
Tachogram after Correction for Mean HR. The table shows the mean and standard deviation for 
each frequency domain index at each the baseline (Base), 30 minutes post supplement 
consumption (30), immediately post exercise (Post), and 60 minutes post supplement 
consumption (60). 
  Base 30 Post 60 
Index Units Mean SD Mean SD Mean SD Mean SD 
TP 10-6 11316 7527 12567 8472 11203 3772 11094 7278 
FFT VLF 10-6 4592 2097 5348 3177 5793 2101 4931 2457 
FFT LF 10-6 4662 3573 4293 3031 3047 1691 3923 2964 
FFT HF 10-6 1916 2650 2681 2793 2149 2049 2056 2639 
FFT LF:HF - 4.50 3.15 2.77 2.68 3.05 3.65 3.77 3.57 
FFT LF n.u. - 0.74 0.13 0.64 0.13 0.60 0.21 0.69 0.14 
FFT HF n.u. - 0.24 0.13 0.33 0.12 0.36 0.20 0.28 0.13 
AR VLF 10-6 4550 2074 5288 3198 5737 2001 4843 2378 
AR LF 10-6 4787 3685 4366 3000 3120 1616 4022 3021 
AR HF 10-6 1833 2493 2669 2855 2124 2009 2044 2641 
AR LF:HF - 4.86 3.40 2.84 2.56 3.18 3.88 3.90 3.56 
AR LF n.u. - 0.75 0.14 0.65 0.13 0.61 0.20 0.70 0.14 
AR HF n.u. - 0.23 0.14 0.32 0.12 0.35 0.19 0.27 0.13 
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5. DISCUSSION 
 The first main finding of this thesis was that the consumption of a caffeine or preworkout 
supplement showed no statistically significant difference as compared to placebo for any HRV 
index measured (both time and frequency domain indices) at baseline or 30 minutes post 
consumption (both measurements during rest and prior to exercise). This suggests that there is no 
change in SNS/PNS activity prior to exercise or that the HRV indices used did not reflect 
changes in SNS/PNS activity because of a possible disconnect between the relationship between 
HRV and SNS/PNS activity. 
 During the placebo trial, it was found that LF power n.u. increased by 0.06 ± 0.03 (mean 
± standard error (SE)) and HF power n.u. decreased 0.05 ± 0.03 (mean ± SE) from prior to 
exercise (30 minutes post consumption) to immediately post exercise. Again, LF Power n.u. 
increased 0.02 ± 0.02 (mean ± SE) and the HF power n.u. decreased 0.02 ± 0.02 (mean ± SE) 
from immediately post exercise to 60 minutes post consumption in the placebo trial. These 
results are consistent with [12]. One of the test groups in [12] performed 3 sets of 20 repetitions 
of six different exercises (bench press, 70° angle leg press, lat pull down, leg curl, biceps curl, 
and 40° leg press) at 40% of a 1 rep max (RM) with 45 seconds between sets and 90 seconds 
between exercises. They also measured LF Power n.u. and HF Power n.u. using an AR model. 
The baseline LF Power n.u. and HF Power n.u. were 0.64 ± 0.03 and 0.36 ± 0.03 (mean ± SE) 
(n=17) respectively for the control trial in [12] as compared to 0.66 ± 0.05 and 0.31 ± 0.05 (mean 
± SE) (n=12) just prior to exercise for the placebo trial (30 minutes post supplement 
consumption) in this study. The LF Power n.u. increased by 0.23 ± 0.04 (mean ± SE) and HF 
Power n.u. decreased by 0.01 ± 0.00 (mean ± SE) in [12] from pre exercise to 20-30 minutes post 
exercise as compared to this study where LF Power n.u. increased by 0.08 ± 0.02 (mean ± SE) 
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and the HF Power n.u. decreased by 0.08 ± 0.02 (mean ± SE) from pre exercise (30 minutes post 
consumption) to approximately 10 minutes post exercise (60 minute post supplement 
consumption).  
The conclusion in [12] states that the respective changes in LF Power n.u. and HF Power 
n.u. suggests an increase in SNS activity and decrease in PNS activity. This agrees with what is 
already known about SNS/PNS activity during exercise, providing additional evidence that the 
measures used (LF Power n.u. and HF Power n.u.) can provide information about SNS/PNS 
activity. 
 During the caffeine trial, contrasting to the placebo trial, it was found that the LF Power 
n.u. decreased 0.04 ± 0.04 (mean ± SE) and the HF Power n.u. increased 0.03 ± 0.04 (mean ± 
SE) from prior to exercise (30 minutes post consumption) to immediately post exercise. Using 
the same rational as used in [12], this result suggests a decrease in SNS activity and an increase 
in PNS activity. This does not agree with the known SNS effects of both exercise and caffeine. 
In addition to this result, there was a statistically significant difference between caffeine and 
placebo at the same time point (post exercise), adding to the significance of this finding. 
The main result that has been found among other caffeine studies is an increase in HF 
power caused by consumption of caffeine [11], which was not found in this study, however it did 
show in increase in HF power n.u.. What was made clear though in [11] is that the impact of 
caffeine on HRV is inconclusive, and this study adds to the body of research already completed 
on caffeine as well as leads research into the effects of preworkout supplements on HRV. 
During the preworkout supplement trial, the LF Power n.u. and HF Power n.u. followed 
the exact same trend as the caffeine trial, however there was no statistically significant difference 
between preworkout and placebo post exercise as in the caffeine trial case (n=12). There was 
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also no statistically significant difference between the preworkout and caffeine trials at any time 
point (baseline, 30 minutes post consumption, post exercise, and 60 post consumption) (n=12). 
The results of this study provide information for an important discussion. The study 
reveals which HRV indices may be sensitive enough to detect statistically significant differences 
between the supplements. The only indices that were shown to be sensitive enough (if 
differences existed) were LF Power n.u. and HF Power n.u. while all of the other frequency 
domain indices as well as all of the time domain indices were not. This suggests that when 
performing studies dealing with caffeine and exercise, and potentially preworkout supplements 
and exercise, LF Power n.u. and HF Power n.u. should be used to detect changes in HRV. 
The second point which needs to be discussed is how LF Power n.u. and HF Power n.u. 
seemed to reflect SNS/PNS activity in agreement with what is expected with a placebo and 
exercise, however the same indices reflect the opposite of what is expected with SNS/PNS 
activity during the caffeine and preworkout trials. This suggests that these indices do not reflect 
the SNS/PNS activity accurately as they have previously been thought to. 
The third point which needs to be discussed is the variability within HRV among 
subjects. Through inspection of the results tables, large variations (leading to large standard 
deviations) in all HRV indices among subjects may be a large contributing factor to why there 
may have been so few time*supplement interaction effects found. There may be multiple reasons 
for this variability, however that doesn’t take away from the fact that this variability should be 
investigated. Along with the variability in measurements, the trends shown by the mean changes 
from baseline, 30 minutes post consumption, post exercise, and 60 minutes post consumption did 
not represent the changes seen for each subject (the changes were inconsistent).  
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The main points of concern are the variability in each HRV index among subjects along 
with the other unpredicted results in this study including decreased SNS activity and increased 
PNS activity based on HRV measurements post exercise during the caffeine trial and 
inconsistency in trends among each subject as compared to the mean changes throughout all 
three trials.  
A proposed reason for these issues is that, even though HRV may reflect some kind of 
autonomic cardiovascular regulation, the interpretation of what these HRV indices reflects is a 
more complex relationship between the autonomic cardiovascular control system and HRV than 
previously thought. Similar statements on the topic have also been made by [17], specifically 
discussing how the LF:HF ratio cannot be used to reflect the SNS/PNS balance. These types of 
discussion force researchers to rethink conclusions made by previous research. It is always 
important to question the validity of conclusions made during early research in any field, 
including early research in HRV analysis, as they are always used as the building blocks for 
future research. In this study there were statistically significant findings for the LF Power n.u. 
and HF Power n.u. which represented unexplainable physiological effects (changes in SNS/PNS 
activity) in the caffeine trial as compared to the placebo trial post exercise. This suggests there 
was not a physiologically significant effect (as opposed to statistically significant) of caffeine 
post exercise as compared to placebo, and that the validity of the relationship between HRV 
measures and SNS/PNS activity should be investigated further. 
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6. LIMITATIONS 
Although the study was performed with much attention to detail, there were however 
some limitations that came along with it. One of the limitations dealing with the calculations of 
HRV was that there was not a stationarity test performed on each ECG recording. A stationarity 
test would have brought forth any ECG recording that is not suited to be analyzed as is without 
any type of de-trending. 
One of the limitations dealing with the preworkout procedure is the lack of time the 
subjects were able to relax prior to the baseline ECG recording. The HRV results showed that, 
even during the placebo trial, many of the HRV indices, both time and frequency domain, had 
changed (visually, but was not investigated statistically) from the baseline measurement to the 30 
minute measurement. This causes reason to believe that although the heart rates seemed to be at 
a baseline level, the HRV values were not at a baseline level (because of the previous discussion, 
it is possible that the changes seen were just general variability in measurements, not that there 
was a physiological change happening). 
Another limitation of the study was the number of subjects. Observing the figures in the 
results section of this thesis, it can be seen that the preworkout supplement had a similar trend (in 
its mean at each time measurement) to the caffeine supplement, however the preworkout 
supplement did not show statistical significance between it and the placebo at any time. It is 
possible that if there were more subjects, the preworkout supplement would have also shown a 
significant difference between it and placebo, similar to that in the case of the caffeine 
supplement. Again, some of the results from this study suggest that the reason that we did not see 
this is because of the large variability among subjects. 
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APPENDIX A. CUBIC SPLINE INTERPOLATION EXAMPLE 
A cubic spline consists of 𝑛 = (# 𝑜𝑓 𝑝𝑜𝑖𝑛𝑡𝑠 𝑜𝑓 𝑑𝑎𝑡𝑎) − 1 continuous piecewise 
function that passes through each data point where all n equations are continuous, even at each 
“knot” (any original data point, which represents the end points for each function in the 
piecewise function). The n equations also have first and second derivatives that are continuous, 
even at the “knots”. Typically with real NN interval data, the data points do not occur at equal 
intervals, and the spline is used to create a continuous piecewise function that represents the data, 
which can be re-sampled for frequency domain analysis. The information for the process of 
creating a cubic spline can be found in [19].  
To demonstrate the concept, the following example shows how to determine a cubic 
spline for a 10-point, aperiodic signal that was originally sampled at equal intervals (unlike a 
tachogram that was sampled an unequal intervals), for simplicity of demonstration, at 1 Hz. 
Let 𝑥[𝑛] = [1 3 8 4 9 2 5 6 2 7]. 
The cubic spline of the signal 𝑥[𝑛] is represented by a piecewise function consisting of 
𝑛 = (10) − 1 = 9 cubic functions. Note that the cubic spline consists of 4𝑛 = 4(9) = 36 
unknowns. To solve for 36 unknowns, there must be 36 equations. x in each of the following 
functions represents the time at which the points of 𝑥[𝑛] occurred. Because 𝑥[𝑛] in this example 
was sampled at equal intervals, the time at which each points occurred started at 𝑡 = 0 and 
increased at intervals ∆𝑇 =
1
𝑓𝑠
= 1 𝑠 up to 
# 𝑜𝑓 𝑝𝑜𝑖𝑛𝑡𝑠 𝑖𝑛 𝑥
𝑓𝑠
−
1
𝑓𝑠
=
(10)
(1 𝐻𝑧)
−
1
(1 𝐻𝑧)
= 9 𝑠. Equation 2 
shows the 9 cubic functions that make up the cubic spline. 
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 𝑆3,9 =
{
 
 
 
 
 
 
 
 
 
 
𝑝1(𝑥) = 𝑎1 + 𝑏1𝑥 + 𝑐1𝑥
2 + 𝑑1𝑥
3,   𝑥 ∈ [𝑥0, 𝑥1]
𝑝2(𝑥) = 𝑎2 + 𝑏2𝑥 + 𝑐2𝑥
2 + 𝑑2𝑥
3,   𝑥 ∈ [𝑥1, 𝑥2]
𝑝3(𝑥) = 𝑎3 + 𝑏3𝑥 + 𝑐3𝑥
2 + 𝑑3𝑥
3,   𝑥 ∈ [𝑥2, 𝑥3]
𝑝4(𝑥) = 𝑎4 + 𝑏4𝑥 + 𝑐4𝑥
2 + 𝑑4𝑥
3,   𝑥 ∈ [𝑥3, 𝑥4]
𝑝5(𝑥) = 𝑎5 + 𝑏5𝑥 + 𝑐5𝑥
2 + 𝑑5𝑥
3,   𝑥 ∈ [𝑥4, 𝑥5]
𝑝6(𝑥) = 𝑎6 + 𝑏6𝑥 + 𝑐6𝑥
2 + 𝑑6𝑥
3,   𝑥 ∈ [𝑥5, 𝑥6]
𝑝7(𝑥) = 𝑎7 + 𝑏7𝑥 + 𝑐7𝑥
2 + 𝑑7𝑥
3,   𝑥 ∈ [𝑥6, 𝑥7]
𝑝8(𝑥) = 𝑎8 + 𝑏8𝑥 + 𝑐8𝑥
2 + 𝑑8𝑥
3,   𝑥 ∈ [𝑥7, 𝑥8]
𝑝9(𝑥) = 𝑎9 + 𝑏9𝑥 + 𝑐9𝑥
2 + 𝑑9𝑥
3,   𝑥 ∈ [𝑥8, 𝑥9]}
 
 
 
 
 
 
 
 
 
 
 (2) 
 
Interpolation creates 𝑛 + 1 = (9) + 1 = 10 equations. Interpolation is defined by 
Equation 3. 
 𝑝𝑖(𝑥𝑖−1) = 𝑓𝑖−1 and 𝑝𝑖(𝑥𝑖) = 𝑓𝑖 for 𝑖 = 1, 2, … , 𝑛 (3) 
 
There were 26 additional equations that had to be determined. Using the fact that the 
piecewise function is continuous at the “interior knots” creates 𝑛 − 1 = (9) − 1 = 8 equations. 
Continuity at the “interior knots” is defined by Equation 4. 
 𝑝𝑖(𝑥𝑖) = 𝑝𝑖+1(𝑥𝑖) for 𝑖 = 1, 2, … , 𝑛 − 1 (4) 
 
There were 18 additional equations that had to be determined. Using the fact that the first 
derivative of the piecewise function is continuous at the “interior knots” creates 𝑛 − 1 = (9) −
1 = 8 equations. Continuity of the first derivative at the “interior knots” is defined by Equation 
5. 
 𝑝𝑖
′(𝑥𝑖) = 𝑝𝑖+1
′ (𝑥𝑖) 𝑓𝑜𝑟 𝑖 = 1, 2, … , 𝑛 − 1 (5) 
 
There were 10 additional equations that had to be determined. Using the fact that the 
second derivative of the piecewise function is continuous at the “interior knots” creates 𝑛 − 1 =
(9) − 1 = 8 equations. Continuity of the second derivative at the “interior knots” is defined by 
Equation 6. 
 𝑝𝑖
′′(𝑥𝑖) = 𝑝𝑖+1
′′ (𝑥𝑖) 𝑓𝑜𝑟 𝑖 = 1, 2,… , 𝑛 − 1 (6) 
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There were only 2 additional equations that had to be determined. There are a few 
methods that can be used to achieve the last 2 equations. A typical method is to apply the “not-a-
knot” conditions. The “not-a-knot” conditions declare that the third derivative of the function on 
each side of the first and last “interior knot” are equal. The “not-a-knot” conditions are defined 
by Equation 7. 
 𝑝1
′′′(𝑥1) = 𝑝1
′′′(𝑥1) and 𝑝𝑛−1
′′′ (𝑥𝑛−1) = 𝑝𝑛
′′′(𝑥𝑛−1) (7) 
 
There were then 36 equations to solve for 36 unknowns. The MATLAB spline command 
solves the system of equations, creates the cubic spline, and re-samples it at a specified 
frequency very efficiently. Figure A1 shows the original signal plotted vs time, Figure A2 shows 
the cubic spline of the signal plotted vs time, and Figure A3 shows the re-sampled cubic spline of 
the original signal at a frequency of 𝑓𝑠 = 2 𝐻𝑧. 
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Figure A1. The Sample Signal x vs Time. 
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Figure A2. The Cubic Spline of the Sample Signal x vs Time. The figure shows the cubic spline 
(continuous waveform) of the sample signal x before it has been resampled. 
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Figure A3. The Signal x Plotted vs Time after Resampling of Cubic Spline. The cubic spline of x 
was resampled at 2 Hz. 
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APPENDIX B. FAST FOURIER TRANSFORM (FFT) EXAMPLE 
For HRV analysis, an FFT is performed to determine the PSD to gain information about 
the frequency components in a tachogram. An FFT is a more efficient method (typically present 
in computer programs such as MATLAB) of calculating the Discrete Fourier Transform (DFT). 
The values calculated by each are equivalent. The DFT is defined by Equation 8. Note that the 
DFT results in a series of discrete points (not a continuous waveform). 
 
𝑋[𝑟] = ∑ 𝑥[𝑘]𝑒−𝑗(2𝜋𝑘𝑟/𝑀)
𝑁−1
𝑘=0
 (8) 
 
where 𝑥[𝑘] is a discrete time signal, 𝑀 is the number of DFT points desired, and 𝑁 is the 
number of points in 𝑥[𝑘]. Typically, 𝑀 = 𝑁, so if 𝑀 > # 𝑜𝑓 𝑝𝑜𝑖𝑛𝑡𝑠 𝑖𝑛 𝑥[𝑘], then 𝑥[𝑘] is “zero 
padded” (completed by adding trailing zeros to the signal) so that 𝑁, the length of 𝑥[𝑘], is still 
equal to 𝑀. Zero padding the signal increases the resolution of the DFT and is commonly 
performed with frequency domain analysis on a tachogram.  
The DFT consists of complex values (values with real and imaginary parts), however in 
this case, only the magnitude of each complex value is important (the phase can be ignored). The 
magnitude can be calculated by squaring the real and imaginary parts, adding them together, and 
then taking the square root. The magnitude values can then be manipulated to determine the 
PSD. The following example shows how to calculate the DFT of a signal and determine its PSD. 
The information describing this process was found in [4] and [18]. Also, the MATLAB fft 
command can calculate an 𝑁 point DFT very efficiently, but be aware that the output must be 
modified in the same manner as in the following example. 
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B.1. Discrete Fourier Transform (DFT) 
Determine the power spectral density (PSD) of a 10-point aperiodic signal that was 
sampled at a rate, 𝑓𝑠, of 2 𝐻𝑧: 
Let 𝑥[𝑛] = [1 3 8 4 9 2 5 6 2 7]. 
The original signal plotted vs time is shown in Figure B1. 
 
Figure B1. The Sample Signal x vs Time. 
Before calculating the DFT, subtract the mean of the signal from the signal as in HRV 
analysis. The signal with its mean subtracted is shown in Figure B2. 
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Figure B2. Sample Signal x vs Time after Subtracting its Mean. 
Using Equation 8, the 10-point DFT was calculated and is shown in Figure B3. 
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Figure B3. Discrete Fourier Transform (DFT) of Sample Signal x. The figure shows the DFT of 
Sample Signal x on a complex plane (real vs imaginary). 
B.2. Unscaled Amplitude (Peak), Two Sided Frequency Spectrum 
The conversion from the DFT to an unscaled amplitude (peak), two sided frequency 
spectrum is described by Equation 9. 
 𝑋𝑈𝑛𝑠𝑐𝑎𝑙𝑒𝑑 𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒 (𝑃𝑒𝑎𝑘),𝑇𝑤𝑜 𝑆𝑖𝑑𝑒𝑑[𝑟]
= √(𝑅𝑒𝑎𝑙 𝑃𝑎𝑟𝑡 𝑜𝑓 𝑋[𝑟])2 + (𝐼𝑚𝑎𝑔𝑖𝑛𝑎𝑟𝑦 𝑃𝑎𝑟𝑡 𝑜𝑓 𝑋[𝑟])2 
(9) 
 
The unscaled amplitude (peak), two sided frequency spectrum of x is shown in Figure 
B4. 
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Figure B4. The Unscaled Amplitude (Peak), Two Sided Frequency Spectrum of Sample Signal x. 
The figure shows the unscaled amplitude (peak), two sided frequency spectrum of sample signal 
x as a function of DFT points (0-9). 
B.3. Scaled Amplitude (Peak), Two Sided Frequency Spectrum 
The conversion from the unscaled amplitude (peak), two sided frequency spectrum to the 
scaled amplitude (peak), two-sided frequency spectrum is done by scaling each amplitude by 
dividing by the number of points in 𝑥 and is shown in Equation 10. 
 
𝑋𝑆𝑐𝑎𝑙𝑒𝑑 𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒 (𝑃𝑒𝑎𝑘),𝑇𝑤𝑜 𝑆𝑖𝑑𝑒𝑑[𝑟] =
𝑋𝑈𝑛𝑠𝑐𝑎𝑙𝑒𝑑 𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒 (𝑃𝑒𝑎𝑘),𝑇𝑤𝑜 𝑆𝑖𝑑𝑒𝑑[𝑟]
# 𝑜𝑓 𝑝𝑜𝑖𝑛𝑡𝑠 𝑖𝑛 𝑥
 (10) 
The scaled amplitude (peak), two sided frequency spectrum of x is shown in Figure B5. 
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Figure B5. The Scaled Amplitude (Peak), Two Sided Frequency Spectrum of Sample Signal x. 
The figure shows the scaled amplitude (peak), two sided frequency spectrum of sample signal x 
as a function of DFT points (0-9). 
 
B.4. Scaled Amplitude (Peak), One Sided Frequency Spectrum 
The conversion from the scaled amplitude (peak), two sided frequency spectrum of x to 
the scaled amplitude (peak), one-sided frequency spectrum is described here. The first element of 
the DFT corresponds to the zero frequency. The midpoint of the DFT (or the point just to the 
right of the midpoint if the length is even), corresponding to half the sampling frequency of the 
data, is the Nyquist Point. For the 10-point DFT, the midpoint is at 
𝑁−1
2
=
(10)−1
2
= 4.5. Because 
the 10-point DFT is even in length (10), the midpoint is actually the point to the right of the 
calculated midpoint. The calculated midpoint is therefore 5. To determine the unscaled, one 
sided frequency spectrum, multiply all of the DFT elements non-zero frequencies (1 ≤ 𝑟 ≤ 5) 
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components by 2. The scaled amplitude (peak), one sided frequency spectrum of x is shown in 
Figure B6. 
 
Figure B6. The Scaled Amplitude (Peak), One Sided Frequency Spectrum of Sample Signal x. 
The figure shows the scaled amplitude (peak), one sided frequency spectrum of sample signal x 
as a function of DFT points (0-5) 
 
B.5. Scaled Amplitude (Root Mean Square (RMS)), One Sided Frequency Spectrum 
The conversion from the scaled amplitude (peak), one sided frequency spectrum of x to 
the scaled amplitude (root mean square (RMS)), one sided frequency spectrum is done by 
dividing each non-zero frequency value by √2. The scaled amplitude (RMS), one sided 
frequency spectrum of x is shown in Figure B7. 
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Figure B7. The Scaled Amplitude (RMS), One Sided Frequency Spectrum of Sample Signal x. 
The figure shows the scaled amplitude (RMS), one sided frequency spectrum of sample signal x 
as a function of DFT points (0-5). 
 
B.6. Power Spectrum 
The conversion from the scaled amplitude (RMS), one sided frequency spectrum of x to 
the Power Spectrum is done by squaring each value of the scaled amplitude (RMS), one sided 
frequency spectrum. The power spectrum is x is shown in Figure B8. 
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Figure B8. The Power Spectrum of Sample Signal x. The figure shows the power spectrum of 
sample signal x as a function of DFT points (0-5). 
 
B.7. Power Spectral Density (PSD) 
The conversion from Power Spectrum to the PSD is done by dividing by the ∆𝑓 spacing 
as shown in Equation 11. 
 
𝑋𝑃𝑆𝐷[𝑟] =
𝑋𝑃𝑜𝑤𝑒𝑟 𝑆𝑝𝑒𝑐𝑡𝑟𝑢𝑚[𝑟]
∆𝑓
=
𝑋𝑃𝑜𝑤𝑒𝑟 𝑆𝑝𝑒𝑐𝑡𝑟𝑢𝑚[𝑟]
𝐹𝑠
# 𝑜𝑓 𝑝𝑜𝑖𝑛𝑡𝑠 𝑖𝑛 𝑥⁄
 (11) 
Because the PSD’s independent variable is data points, it was necessary to convert the 
independent variable to frequency for better interpretation of the PSD. The first PSD element 
corresponds to the zero frequency and the last PSD element corresponds to the frequency 𝑓 =
𝑓𝑠
2
. 
The remaining PSD elements correspond to frequencies equally spaced between zero and 𝑓 =
𝑓𝑠
2
. 
 64 
The increment is equal to ∆𝑓 =
𝑓𝑠
𝑁
=
(2 𝐻𝑧)
(10)
= 0.2 𝐻𝑧. Therefore the six PSD elements correspond 
to the frequencies 0, 0.2, 0.4, 0.6, 0.8, 𝑎𝑛𝑑 1 𝐻𝑧. The PSD of x using an FFT is shown in Figure 
B9. 
 
Figure B9. The Power Spectral Density (PSD) of Sample Signal x Using an FFT. The figure 
shows the PSD of sample signal x using an FFT as a function of frequency. 
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APPENDIX C. AUTOREGRESSIVE (AR) MODEL EXAMPLE 
An autoregressive (AR) model is a model that predicts each data point of a data set based 
on a specific number of previous data points that are each weighted. With each prediction comes 
an error from the actual data point. The number of previous data points used for the prediction is 
the model order. The AR model is defined by Equation 12. 
 
𝑥[𝑛] =∑𝑎𝑖𝑥[𝑛 − 𝑖] + 𝜀[𝑛]
𝑀
𝑖=0
 (12) 
 
Where 𝑀 is the model order and 𝑎𝑖 represents the coefficients for the AR model. It can 
be seen that any set of coefficients can be used for prediction using a particular model order, but 
a certain set of coefficients can lead to a lot of error for each data prediction. There are many 
ways to describe the error based on a certain set of coefficients, but the most typical way is to 
determine the error is by the sum squared error (SSE). The goal then is to choose a set of 
coefficients that minimizes the SSE for a chosen model order. One method of choosing the 
coefficients to minimize this sum squared error is the Levinson-Durbin recursion algorithm. 
Information on AR models and the Levinson-Durbin algorithm derivation can be found in [20] 
and [21]. 
C.1. Power Spectral Density (PSD) 
To determine the PSD using an AR model, first, the AR model coefficients must be 
determined (Levinson-Durbin Algorithm). Once the coefficients have been determined, the 
transfer function of the AR model must be determined. The transfer function of the AR model is 
defined by Equation 13. Note that the transfer function of the AR model is a continuous function 
(unlike the discrete function in the DFT case). 
 
𝐻(𝑧) =
1
∑ 𝑎𝑖𝑧−𝑖
𝑀
𝑖=0
 (13) 
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Once the AR synthesis filter is determined, the AR synthesis filter can be modified to 
determine the transfer function for power spectral density. The transfer function for power 
spectral density is defined by Equation 14. 
 
𝑃𝑆𝐷(𝑧) =
2𝐸𝑀
|∑ 𝑎𝑖𝑧−𝑖
𝑀
𝑖=0 |
2 ∗
1
𝑓𝑠 ∗ (# 𝑜𝑓 𝑝𝑜𝑖𝑛𝑡𝑠 𝑖𝑛 𝑥)
 (14) 
 
Where 𝐸𝑀 is the prediction error variance and 𝑓𝑠 is the sampling frequency of the data in 
𝑥[𝑛]. 
C.2. Levinson-Durbin Algorithm 
The Levinson-Durbin recursion algorithm is used to determine the coefficients for an AR 
model while minimizing the mean squared error (MSE). The algorithm is a recursion algorithm, 
meaning that if a 3rd order model is desired, the coefficients must first be determined for the 1st 
order model, the 2nd order model, and finally the 3rd order model. The Levinson-Durbin 
algorithm is defined by these steps from [20] with slight modifications in syntax: 
1. Compute 𝑅𝑗 for 0 ≤ 𝑗 ≤ 𝑀 where 𝑅𝑙 = ∑ 𝑦𝑛𝑦𝑛+𝑙
∞
𝑛=−∞  
2. Calculate 𝐴1 = [
𝑎0
1
𝑎1
1] = [
1
−
𝑅1
𝑅0
] 
3. Calculate 𝐸1 = 𝑅0 + 𝑅1𝑎1
1 
4. For 1 ≤ 𝑘 ≤ 𝑀 − 1: 
a. 𝜆𝑘+1 =
−∑ 𝑎𝑗
𝑘𝑘
𝑗=0 𝑅𝑘+1−𝑗
𝐸𝑘
 
b. 𝐴𝑘+1 = 𝑈𝑘+1 + 𝜆𝑘+1𝑉𝑘+1 
c. 𝐸𝑘+1 = (1 − 𝜆𝑘+1
2)𝐸𝑘 
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Where 𝐴𝑘+1 =
[
 
 
 
 
1
𝑎1
𝑘+1
𝑎2
𝑘+1
⋮
𝑎𝑘+1
𝑘+1]
 
 
 
 
, 𝑈𝑘+1 =
[
 
 
 
 
 
0
𝑎1
𝑘
𝑎2
𝑘
⋮
𝑎𝑘
𝑘
1 ]
 
 
 
 
 
, and 𝑉𝑘+1 =
[
 
 
 
 
 
1
𝑎𝑘
𝑘
⋮
𝑎2
𝑘
𝑎1
𝑘
0 ]
 
 
 
 
 
. 
𝐴1 and 𝑎
𝑘 represent all of the coefficients for the model order 𝑘. For example, 𝐴3 
includes the coefficients 𝑎0
3, 𝑎1
2, 𝑎2
3, and 𝑎3
3. 𝑎2
3 is the coefficient that corresponds to the second 
lag value (the weight placed on the second preceding data point already known) of the for a 3th 
order model. 𝐸𝑘 is the prediction error variance and 𝜆𝑘 is the reflection coefficient for model 
order 𝑘. It is known that the prediction error variance will keep decreasing as the model order 
increases, however increasing the model order increases the complexity of the model. There are 
methods that can be used, which are not discussed here, to determine the optimal model order.  
The following example shows how to create an AR model using the Levinson-Durbin 
recursion algorithm, and how to determine the PSD from it. Also, the MATLAB levinson 
command can easily solve for the AR model coefficients, reflection coefficient, and prediction 
error variance for any model order very efficiently. Be aware that the output of the command 
must be modified in the same fashion as the example below to determine the PSD. 
Calculate the power spectral density (PSD) of an aperiodic signal that was sampled at a 
rate, 𝑓𝑠, of 2 𝐻𝑧 using a 3
rd order autoregressive (AR) model: 
Let 𝑥[𝑛] = [1 3 8 4 9 2 5 6 2 7]. 
The original signal vs time is shown in Figure C1. 
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Figure C1. The Sample Signal x vs Time. 
 
Before determining the AR model, mean of the signal was subtracted from the signal as 
in HRV analysis. The signal with its mean subtracted is shown in Figure C2. 
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Figure C2. The Sample Signal x with its Mean Removed. 
 
C.3. Third Order AR Model 
To determine a 3nd order model, the Levinson-Durbin Algorithm was followed with a 
model order 𝑀 = 3. 
C.3.1. Power Spectral Density (Z Domain) 
Once the autoregressive model coefficients and prediction error variance were 
determined and the corresponding AR synthesis filter, is could then be converted to create the 
PSD. The equation for the PSD of x (z domain) using a 3rd order AR model is defined by 
Equation 15. The equation is defined in the z domain which is fine, but is more useful when it is 
defined in the absolute frequency domain. 
 
𝐻3,𝑃𝑆𝐷(𝑧) =
2(57.40)
|1 + (0.423)𝑧−1 + (0.094)𝑧−2 + (0.009)𝑧−3|2
∗
1
(2 𝐻𝑧) ∗ (10)
 (15 ) 
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C.3.2. Power Spectral Density (in Terms of Real Frequency) 
The PSD in the z domain was converted to the absolute frequency domain. The 
conversion from the z domain to the absolute frequency domain is described by Equation 16. 
 
𝑧 = 𝑒𝑗𝜔𝑇 = 𝑒𝑗2𝜋𝑓𝑇 = 𝑒
𝑗2𝜋𝑓
𝑓𝑠
⁄
 (16) 
 
The conversion was completed and the PSD of x (absolute frequency domain) using a 3rd 
order AR model is defined by Equation 17. 
 𝐻3,𝑃𝑆𝐷(𝑓)
=
2(57.40)
|1 + (0.423)𝑒
−𝑗2𝜋𝑓
(2 𝐻𝑧)⁄ + (0.094)𝑒
−𝑗4𝜋𝑓
(2 𝐻𝑧)⁄ + (0.009)𝑒
−𝑗6𝜋𝑓
(2 𝐻𝑧)⁄ |
2
∗
1
(2 𝐻𝑧) ∗ (10)
 
(17) 
 
Because the sampling frequency was 2 Hz, by Nyquist’s Theorem, the highest frequency 
that can be plotted is 1 Hz. The resulting PSD vs absolute frequency plotted over a continuous 
range of frequencies is shown in Figure C3. 
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Figure C3. The Power Spectral Density (PSD) of x Using a 3rd Order Autoregressive (AR) 
Model. The figure shows the PSD of x using a 3rd order AR model as a function of frequency. 
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APPENDIX D. VALIDATION OF MATLAB SOFTWARE PACKAGE 
Before using MATLAB commands to determine time and frequency domain indices of 
HRV for a real tachogram, it was necessary to validate the commands by inputting a simple 
known discrete signal, which was used to simulate a real tachogram, into the system and 
compare the results with those performed by hand calculations. The following example shows 
how the time and frequency domain indices of HRV were calculated by hand for a simulated 
tachogram. It is understood that a real tachogram has data points that are spaced at unequal 
intervals, but to simplify the hand calculations for time and frequency domain indices of the 
simulated tachogram, the simulated tachogram is completely periodic and has data points that are 
all spaced at equal intervals. 
D.1. Simulate Tachogram (Create Discrete Waveform) 
Let 𝑥(𝑡) = 𝐴1 sin(2𝜋𝑓1𝑡) +𝐴2 sin(2𝜋𝑓2𝑡) + 𝐴3  𝑚𝑠 for 0 ≤ 𝑡 ≤ 𝑡𝑒𝑛𝑑.  
If the continuous signal 𝑥(𝑡) is sampled at 𝑓𝑠, the continuous signal becomes the discrete 
signal 
𝑥[𝑛] = 𝐴1 sin(2𝜋𝑓1𝑛∆𝑡) +𝐴2 sin(2𝜋𝑓2𝑛∆𝑡) + 𝐴3  𝑚𝑠 where ∆𝑡 =
1
𝑓𝑠
 and 0 ≤ 𝑛 ≤
𝑡𝑒𝑛𝑑
∆𝑡
. 
Let 𝐴1 = 10, 𝐴2 = 20, 𝐴3 = 1000, 𝑓1 = 0.1 𝐻𝑧, 𝑓2 = 0.2 𝐻𝑧, 𝑓𝑠 = 0.8 𝐻𝑧, and 𝑡𝑒𝑛𝑑 =
300 𝑠. Therefore, ∆𝑡 =
1
𝑓𝑠
=
1
(0.8 𝐻𝑧)
= 1.25 𝑠 and 0 ≤ 𝑛 ≤ 𝑁 =
𝑡𝑒𝑛𝑑
∆𝑡
=
(300 𝑠)
(1.25 𝑠)
= 240. 
D.2. HRV Measures Using Original Tachogram 
Once the simulated tachogram was created, it was possible to perform time and frequency 
analysis on the tachogram, before and after the tachogram was corrected for average heart rate. 
D.2.1. Time Domain Indices 
To determine the time domain indices, it was necessary to know every data point. 
Because the waveform is periodic, it is easier to describe all of the points by gaining information 
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from a single period. To determine the length of one period of the signal, the greatest common 
denominator of the frequencies in the waveform had to be determined. The greatest common 
denominator of the two frequencies in the waveform is 𝑓𝐺𝐶𝐷 = 𝑓1 = 0.1 𝐻𝑧, therefore one period 
of the signal is 𝑡𝑝𝑒𝑟𝑖𝑜𝑑 =
1
𝑓𝐺𝐶𝐷
=
1
(0.1 𝐻𝑧)
= 10 𝑠. 0 ≤ 𝑛 ≤
𝑡𝑝𝑒𝑟𝑖𝑜𝑑
∆𝑡
=
(10 𝑠)
(1.25 𝑠)
= 8. The period is 8 
units and there are 
241
8
=
240
8
+
1
8
= 30
1
8
 𝑝𝑒𝑟𝑖𝑜𝑑𝑠 = 30 𝑝𝑒𝑟𝑖𝑜𝑑𝑠 + 1 𝑒𝑥𝑡𝑟𝑎 𝑝𝑜𝑖𝑛𝑡. The data for 
the first period is shown in Figure D1. 
 
Figure D1. The First 8 Points of the Simulated Tachogram (NN Intervals vs Time). The figure 
shows the first period (8 points) of the simulated tachogram. 
 
For some of the time domain indices, it was necessary to determine the ∆NN intervals. 
Much like the tachogram, the ∆NN vs time data is also periodic. The period is still 8 units, 
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however the number of periods is different because there is less data points. There are 
240
8
=
30 𝑝𝑒𝑟𝑖𝑜𝑑𝑠. The data for the first period of the ∆NN intervals vs time is shown in Figure D2. 
 
Figure D2. The ∆NN Intervals vs Time of the Simulated Signal. 
 
D.2.2. Frequency Domain Indices 
The total power was calculated by determining the variance of all the data points. The  
VLF, LF, and HF power were determined by looking at the frequencies present in the signal (0, 
0.1 and 0.2 Hz as declared when the simulated signal was created) and determining the 
corresponding power present at each frequency. The power at 0 Hz is always zero because the 
mean is removed before performing frequency domain analysis. The power at the nonzero 
frequencies is defined by Equation 18. 
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 𝑃𝑜𝑤𝑒𝑟𝑓
= (
𝑀𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒 𝑜𝑓 𝑆𝑖𝑛𝑢𝑠𝑜𝑖𝑑𝑎𝑙 𝐶𝑜𝑚𝑝𝑜𝑛𝑒𝑛𝑡 𝑎𝑡 𝑓 
√2
)2 
(18) 
 
Once the power at each frequency was determined, it was placed into the corresponding 
frequency range (VLF, LF, or HF) that it belonged. 
D.3. HRV Measures Using Tachogram Corrected for Average Heart Rate 
HRV measures as determined by tachogram corrected for mean HR was performed the 
same way as those determined by the original tachogram. To determine the tachogram that was 
corrected for mean HR, all of the data points in the original tachogram were divided by the mean 
NN interval.  
 
D.3.1. Time Domain Indices 
The time domain indices were calculated in the same manner as those calculated for the 
original tachogram. The tachogram that was corrected for mean HR is shown in Figure D3, and 
the ∆NN intervals vs time from the tachogram that was corrected for mean HR is shown in 
Figure D4.  
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Figure D3. The Simulated Tachogram (NN Intervals vs Time) after Correction for Mean Heart 
Rate. The figure shows the simulated tachogram after dividing all NN intervals by the mean NN 
interval. 
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Figure D4. The ∆NN Intervals vs Time after Correction for Mean Heart Rate. 
 
D.3.2. Frequency Domain Indices 
Frequency domain analysis for the original tachogram after correction for mean HR was 
performed in the same manner as frequency domain analysis for the original tachogram. 
D.4. Validation 
Comparisons between HRV analysis performed by hand to the calculations performed by 
MATLAB functions were completed for both HRV analysis performed on the original simulated 
tachogram and the original simulated tachogram after correction for mean HR. Table D1 shows 
the summary of the amount of data (gained from simulated signal) used for the HRV analysis. 
Table D2 shows the comparison for HRV analysis performed on the original simulated 
tachogram and Table D3 shows the comparison for the HRV analysis performed on the original 
simulated tachogram after correction for mean HR. 
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Table D1. Comparison of the Amount of Data Used for HRV Analysis of Simulated Tachogram. 
The star represents an absolute error in cases where the program value was compared to a 
theoretical value of zero. 
Index Units Theoretical 
Value 
Program Percent Error (%) 
# of NN # 241 241 0 
# of ∆NN # 240 240 0 
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Table D2. The Comparison of HRV Analysis Performed on Original Simulated Tachogram. The 
star represents an absolute error in cases where the program value was compared to a theoretical 
value of zero. 
Index Units Theoretical 
Value 
Program Percent Error (%) 
Min NN 𝑚𝑠 772.9 772.9 0 
Max NN 𝑚𝑠 827.1 827.1 0 
Mean NN 𝑚𝑠 800 800 0 
SDNN 𝑚𝑠 15.811 15.811 0 
rMSSD 𝑚𝑠 20.763 20.763 0 
Ln(rMSSD) − 3.03 3.03 0 
pNN50 % 0 0 *0 
pNN40 % 0 0 *0 
pNN30 % 0 0 *0 
pNN20 % 50 50 0 
pNN10 % 100 100 0 
Mean Delta 
NN 
𝑚𝑠 0 0 *0 
SD of Delta 
NN 
𝑚𝑠 20.763 20.763 0 
Triangular 
Index 
− 3.951 3.951 0 
FFT TP 𝑚𝑠2 250 244.136 -2.3 
FFT VLF 𝑚𝑠2 0 0.568 *0.6 
FFT LF 𝑚𝑠2 50 50.513 1.0 
FFT HF 𝑚𝑠2 200 192.811 -3.6 
FFT LF:HF − 0.25 0.262 4.8 
AR TP 𝑚𝑠2 250 244.136 -2.3 
AR VLF 𝑚𝑠2 0 0.479 *0.479 
AR LF 𝑚𝑠2 50 50.999 2.0 
AR HF 𝑚𝑠2 200 192.422 -3.8 
AR LF:HF 𝑚𝑠2 0.25 0.265 6 
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Table D3. The Comparison of HRV Analysis Performed on Original Simulated Tachogram after 
Correction for Mean HR. The star represents an absolute error in cases where the program value 
was compared to a theoretical value of zero. 
Index Units Theoretical 
Value 
Program Percent Error (%) 
Min NN 10−3 𝑈𝑛𝑖𝑡𝑠 966.2 966.2 0 
Max NN 10−3 𝑈𝑛𝑖𝑡𝑠 1033.8 1033.8 0 
Mean NN 10−3 𝑈𝑛𝑖𝑡𝑠 1000 1000 0 
SDNN 10−3 𝑈𝑛𝑖𝑡𝑠 19.764 19.764 0 
rMSSD 10−3 𝑈𝑛𝑖𝑡𝑠 25.953 25.953 0 
Ln(rMSSD) − 3.26 3.26 0 
pNN50 % 0 0 *0 
pNN40 % 0 0 *0 
pNN30 % 25 25 0 
pNN20 % 75 75 0 
pNN10 % 100 100 0 
Mean Delta 
NN 
10−3 𝑈𝑛𝑖𝑡𝑠 0 0 *0 
SD of Delta 
NN 
10−3 𝑈𝑛𝑖𝑡𝑠 25.953 25.953 0 
Triangular 
Index 
− 3.951   
FFT TP 10−6 𝑈𝑛𝑖𝑡𝑠2 390.625 381.46 -2.3 
FFT VLF 10−6 𝑈𝑛𝑖𝑡𝑠2 0 0.888 *0.888 
FFT LF 10−6 𝑈𝑛𝑖𝑡𝑠2 78.125 78.927 1.0 
FFT HF 10−6 𝑈𝑛𝑖𝑡𝑠2 312.5 301.27 -3.6 
FFT LF:HF − 0.25 0.262 4.8 
AR TP 10−6 𝑈𝑛𝑖𝑡𝑠2 390.625 381.46 -2.3 
AR VLF 10−6 𝑈𝑛𝑖𝑡𝑠2 0 0.748 *0.748 
AR LF 10−6 𝑈𝑛𝑖𝑡𝑠2 78.125 79.686 2.0 
AR HF 10−6 𝑈𝑛𝑖𝑡𝑠2 312.5 300.66 -3.8 
AR LF:HF − 0.25 0.265 6 
 
There was no error present in the time domain indices, however there was some nonzero 
error in all of the frequency domain indices. The following discussion explains why it was 
expected that there was a small, nonzero error in the frequency domain indices. The total power 
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of the signal, when performing hand calculations, was calculated by determining the variance of 
the signal, because the total power of a signal is equal to the variance of a signal. The total power 
of the signal, when using MATLAB, was calculated by performing an interpolation by creating a 
cubic spline and re-sampling it at 2 Hz, and then integrating the corresponding PSD from 0 to 1 
Hz. The total power, as determined by the integration from 0 to 1 Hz should be approximately 
equal to the integration over all frequencies, which is known to be equal to the variance of the 
interpolated signal. It makes sense that the variance of the original signal and the interpolated 
signal will be close, but not equal, because of the interpolated signal does not consist of exactly 
the same data as the original signal since it is a different representation of the original signal, 
hence the error. 
 
